Finally, the activation of the HIPK2 and p53 axis by nutlin-3 specifically in MYCN-amplified tumours sensitises tumours to apoptosis [27], thereby supporting that the strategy consisting of reactivating p53 in combination with radiotherapy is suitable for the treatment of patients with high risk neuroblastoma. The gene discussed is TP53; the disease is neoplasm.